Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 30 June 2014
|
|
- Winfred Glenn
- 5 years ago
- Views:
Transcription
1 Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 3 June The cumulative cases report since December 21 and cases report during April to June 214 During 1 April to 3 June 214, there were 52 cases reported through the severe pneumonia database from 13 provinces including of 6 deaths (one autopsy). Thirteen cases were reported from Surat Thani, Chiang Mai 8 cases, Phra Nakhon Si Ayutthaya 6 cases, Prachuap Khiri Khan, Si Sa Ket and Kamphaeng Phet 5 cases each, Chanthaburi 3 cases, Saraburi 2 cases, Phetchaburi, Sukhothai, Nakhon Si Thammarat, Chiang Rai and Kanchanaburi 1 case each.(figure 1) By Thirty-two cases were male and 2 were female. Female to male ratio was 1.6:1. Mean age was 33 years old (2 months 95 years). Eighteen cases were children age under 2 year old (34.62%) Since 1 December 21 to 3 June 214 the Bureau of Epidemiology received 622 cases reported through the severe pneumonia database from 17 provinces including 139 deaths (9 cases were autopsy). The highest number was reported from Surat Thani (194), the rest were from cases from Chiang Mai (125), Phra Nakhon Si Ayutthaya (52), Prachuap Khiri Khan (39) and 33 cases reported from Chanthaburi. Of 622 cases, 375 were male and 247 were female. Female to male ratio was 1.52:1. Mean age was 21 years old (2 months 97 years). Three hundred and eighty six cases were children age under 5 years old (62.6%). (Figure 2, 3) 2. Laboratory result All specimens were sent to the National Institute of Health for laboratory testing. Since 1 December 21 to 3 June 214, Of 612 cases, 348 were positive (56.86%). During 1 April to 3 June 214, the pathogens were founded and identified in 27 cases from 47 cases (57.44%). Table 1 shows the laboratory results of both periods.
2 Quarterly cases/deaths Apr - 3 Jun Dec 21-3 Jun Cumulative cases/deaths Surat Thani Chiang Mai Phra Nakhon Si Ayutthaya Prachuap Khiri Khan Chanthaburi Kamphaeng Phet Kanchanaburi Sukhothai Phitsanulok Saraburi Chachoengsao Provinces Si Sa Ket Chiang Rai Phetchaburi Uttaradit Nakhon Si Thammarat Ubon Ratchathani Figure 1 Total number of severe and fatal pneumonia cases reported through the severe pneumonia database by provinces severe pneumonia cases cases (1 April - 3 June 214) cases (1 Dec 21-3 Jun 214) 2 mo.- 5 yrs 6-2 yrs 21-4 yrs 41-6 yrs >6 yrs Age Figure 2 Total number of severe pneumonia cases reported through the severe pneumonia database by age group Cumulative severe pneumonia cases
3 6 Fetal pneumonia cases(1 Apr - 3 Jun 214) Cumulative Fatel pneumonia cases (1 Dec 21-3 Jun 214) 4 Fatal pneumonia cases mo.- 5 yrs 6-2 yrs 21-4 yrs 41-6 yrs >6 yrs Age Cumulative fatsl pneumonia cases Figure 3 Total number of fatal pneumonia cases reported through the severe pneumonia database by age group.
4 Table 1 Laboratory results of reported severe and fatal pneumonia cases through the severe pneumonia database. (Tested by NIH) Pathogens 1 Dec 21 3 Jun Apr 3 Jun 214 Viral infection (from tracheal secretion) Adenovirus 3 23 Coronavirus Enterovirus Human metapneumovirus 1 5/4 Influenza virus A/H1N /4 Influenza virus A/H3 2 7/5 Influenza virus B 1 3 Respiratory syncytial virus 87/9 Parainfluenza virus type 1 8 Parainfluenza virus type 2 3/1 Parainfluenza virus type 3 1 9/3 Mixed viral infection (from tracheal secretion) Respiratory syncytial virus and Human metapneumovirus /1 Parainfluenza virus type 3 and Adenovirus 2 2/1 Parainfluenza virus type 3 and Humanmetapneumovirus Respiratory syncytial virus and Poliovirus type 2, 3 vaccine Respiratory syncytial virus and Influenza virus A/H1N1 29 Influenza virus A/H1N1 29 and Adenovirus Bacterial infection (from tracheal secretion) Chlamydophila pneumoniae 4/2 Mycoplasma pneumoniae 1/5 Haemophilus influenzae 3 7/1 Legionella species Legionella pneumophila Streptococcus pneumoniae 1 2/2 Moraxella catarrhalis 6/1 Klebsiella pneumoniae 4 5/1 Pseudomonas aeruginosa Acinetobacter baumannii /1 Stenotrophomonas maltophilia Escherichia coli 3
5 Pathogens 1 Dec 21 3 Jun Apr 3 Jun 214 Bacterial infection (from tracheal secretion) Staphylococcus aureus 2/4 Burkholderia pseudomallei /2 Acinetobacter calcoaceticus /1*** Bacterial infection (from fresh lung tissue) Staphylococcus coagulase /1*** Chlamydophila pneumoniae /1 Acinetobacter spp. /1** Mixed bacterial infection (from tracheal secretion) Chlamydophila pneumoniae and Moraxella catarrhalis 3 Mycoplasma pneumonaie and Klebsiella pneumoniae Mycoplasma pneumoniae and Moraxella catarrhalis Escherichia coli and Klebsiella pneumoniae /1 5/11 Escherichia coli and Haemophilus influenzae /1 Escherichia coli and Streptococcus pneumoniae /1 Escherichia coli and Burkholderia pseudomallei Escherichia coli and Staphylococcus aureus /1 Escherichia coli, Mycoplasma pneumoniae and Haemophilus influenzae Escherichia coli, Haemophilus influenzae and Moraxella catarrhalis Pseudomonas aeruginosa and Staphylococcus aureus /1 Streptococcus pneumonia and Haemophilus influenzae 1 1 Streptococcus pneumonia and Moraxella catarrhalis Acinetobacter baumannii and Acinetobacter spp. Klebsiella pneumoniae, Moraxella catarrhalis and Staphylococcus aureus Klebsiella pneumoniae and Pseudomonas aeruginosa 1 1 Morganella morganii, Citrobacter freundii (Moderate), Escherichia coil (Moderate), Pseudomonas aeruginosa (Few), gamma-hemolysis Streptococci (Moderate), alpha-hemolysis Streptococci (Moderate) Mixed bacterial infection (from fresh lung tissue) Klebsiella pneumoniae and Acinetobacter lwoffi /1* Mixed bacterial infection (from fresh liver tissue) Escherichia coli and Klebsiella pneumoniae /1*
6 Pathogens 1 Dec 21 3 Jun Apr 3 Jun 214 Co-infection (from tracheal secretion) Adenovirus and Acinetobacter baumannii /1 Adenovirus, Haemophilus influenzae, Moraxella catarrhalis and Escherichia coli Adenovirus and Moraxella catarrhalis Adenovirus, Streptococcus pneumoniae and Haemophilus influenzae /1 Adenovirus and Haemophilus influenzae 1 1 Respiratory syncytial virus and Mycoplasma pneumoniae Respiratory syncytial virus and Streptococcus pneumoniae 3 Respiratory syncytial virus and Klebsiella pneumoniae Respiratory syncytial virus and Escherichia coli Respiratory syncytial virus and Chlamydophila pneumoniae Respiratory syncytial virus and Moraxella catarrhalis 6 Respiratory syncytial virus and Haemophilus influenzae 8 Respiratory syncytial virus, Haemophilus influenzae and Escherichia coli 3 Respiratory syncytial virus, Klebsiella pneumoniae and Escherichia coli Respiratory syncytial virus, Mycoplasma pneumoniae and Haemophilus influenzae Respiratory syncytial virus, Human metapneumovirus and Escherichia coli Respiratory syncytial virus, Parainfluenza virus type 2 and Moraxella catarrhalis Respiratory syncytial virus, Mycoplasma pneumoniae and Streptococcus pneumoniae /1 Influenza virus A/H3 and Streptococcus pneumoniae Influenza virus A/H3 and Staphylococcus aureus /1 Influenza virus A/H3 and Klebsiella pneumoniae /1 Influenza virus A/H3 and Mycoplasma pneumoniae 2 Influenza virus A/H3, Pseudomonas aeruginosa /1 Influenza virus B and Pseudomonas aeruginosa Influenza virus B and Escherichia coli /1 Influenza virus B, Escherichia coli and Mycoplasma pneumoniae Parainfluenza virus type 3, Klebsiella pneumoniae and Escherichia coli /1 Parainfluenza virus type 3, Haemophilus influenzae and Escherichia coli Humanmetapneumovirus and Escherichia coli Humanmetapneumovirus and Haemophilus influenzae /1 Humanmetapneumovirus and Moraxella catarrhalis
7 Pathogens 1 Apr 3 Dec 21 Jun Jun 214 Influenza virus A/H1N1 29 and Moraxella catarrhalis Influenza virus A/H1N1 29 and Acinetobacter baumannii /1 Influenza virus A/H1N1 29, Streptococcus pneumoniae 1 1/1 Influenza virus A/H1N1 29, Streptococcus pneumoniae and Moraxella catarrhalis Influenza virus A/H1N1 29 and Haemophilus influenzae /1 Influenza virus A/H1N1 29, Adenovirus and Acinetobacter baumannii /1** Parainfluenza virus type 2, Haemophilus influenzae and Legionella pneumophila Parainfluenza virus type 2 and Escherichia coli Parainfluenza virus type 1 and Chlamydophila pneumoniae Parainfluenza virus type 1 and Mycoplasma pneumoniae Parainfluenza virus type 1 and Klebsiella pneumoniae /1 /1 Total * Same patient, **Same patient, *** Same patient
Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015
Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015 1. The cumulative cases report since December 2010 and cases report during January to March 2015 During
More informationRespiratory Pathogen Panel TEM-PCR Test Code:
Respiratory Pathogen Panel TEM-PCR Test Code: 220000 Tests in this Panel Enterovirus group Human bocavirus Human coronavirus (4 types) Human metapneumovirus Influenza A - Human influenza Influenza A -
More informationInfluenza A (H1N1)pdm09 in Minnesota Epidemiology
Influenza A (H1N1)pdm09 in Minnesota Epidemiology Infectious Disease Epidemiology, Prevention and Control Division PO Box 64975 St. Paul, MN 55164-0975 Number of Influenza Hospitalizations by Influenza
More informationCreating a User Defined Pneumonia-Specific Syndrome in ESSENCE. Preventive Medicine Directorate September 2016
Creating a User Defined Pneumonia-Specific Syndrome in ESSENCE Preventive Medicine Directorate September 2016 0 Pneumonia-Specific Syndrome NMCPHC retrospective analyses suggest that surveillance using
More informationPotential Reimbursement CPT Codes
BioFire FilmArray Blood Culture Identification (BCID) Panel Medicare All targets (n) 87150 n x * *BioFire BCID Panel is comprised of 27 total targets. The number of targets allowed for reimbursement may
More informationProtocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel
Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel Laboratory Protocols for Use with a ZeptoMetrix NATtrol Verification Panel Purpose The Clinical Laboratory
More informationProtocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel plus
Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel plus Laboratory Protocols for Use with a ZeptoMetrix NATtrol Verification Panel Purpose The Clinical Laboratory
More informationINFECTIOUS DISEASE. Page 2
Infectious disease Advantages OF TESTING INFECTIOUS DISEASE We are in the middle of a paradigm shift in infectious disease diagnostic testing. As we move from targeted infectious disease testing to a syndromic
More informationCefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European
More informationCefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the
More informationPneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?
Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? David Murdoch Department of Pathology University of Otago, Christchurch Outline Background Diagnostic challenges
More informationM O L E C U L A R G E N E T I C S
MOLECULAR GENETICS ADVANTAGES OF MOLECULAR GENETICS Molecular genetics is a dynamic and transformative area of diagnostics, leading to insights in research and treatment in many disease states that are
More informationRESPIRATORY WATCH Week 3 (January 14 to January 20, 2018)*
Number of positive specimens RESPIRATORY WATCH Week (January to January, )* IN SUMMARY Activity levels** Zones, & are reporting localized activity. The is no activity being reported in Zone. There have
More informationRESPIRATORY WATCH Week 2 (January 6, 2019 to January 12, 2019 )*
Number of positive specimens RESPIRATORY WATCH Week (January, to January, )* IN SUMMARY Activity levels** Central and Western Zones have localized activity. Northern and Eastern Zones are reporting sporadic
More informationCDC Cooperative Agreement Influenza Surveillance Review Project Period(Sep 2004-Sep 2011)
CDC Cooperative Agreement Influenza Surveillance Review Project Period(Sep 2004-Sep 2011) National Institute of Health Department of Medical Sciences, Bureau of Epidemiology Department of Disease Control,
More informationConsultation on the Revision of Carbapenem Breakpoints
Consultation on the Revision of Carbapenem Breakpoints July 2018 Please send comments to the EUCAST Scientific Secretary at jturnidge@gmail.com by September 15. EUCAST revision of carbapenem breakpoints
More informationPAMET Continuing Education 2016
PAMET Continuing Education 2016 Agent of gastroenteritis Medium/method] used for routine screening/detection in stool samples Salmonella, Shigella, MacConkey, Hektoen, Bismuth sulfite,etc. Plesiomonas
More information12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents
Objectives Atypical Pneumonia K. Sue Kehl, Ph.D., D(ABMM) Associate Professor, Pathology Medical College of Wisconsin Associate Director of Clinical Pathology & Technical Director of Microbiology, Children's
More informationRespiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract
Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens within the upper and lower respiratory
More informationSyndromic Testing: The right test, the first time.
Syndromic Testing: The right test, the first time. Don t guess. Know. Infectious disease diagnostics has evolved. BioFire s syndromic approach is making the world a healthier place. Many infectious diseases
More informationCommunity Acquired Pneumonia. Abdullah Alharbi, MD, FCCP
Community Acquired Pneumonia Abdullah Alharbi, MD, FCCP A 68 y/ male presented to the ED with SOB and productive coughing for 2 days. Reports poor oral intake since onset due to nausea and intermittent
More informationRetrospective and Prospective Verification of the Cepheid Xpert Flu Assay
JCM Accepts, published online ahead of print on 20 July 2011 J. Clin. Microbiol. doi:10.1128/jcm.01162-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationSUPPLEMENTARY MATERIAL
SUPPLEMENTARY MATERIAL (A) Further inclusion criteria and categorisation of ICD-10 diagnostic codes Pneumonia: A310 Pulmonary mycobacterial infection A420 Pulmonary actinomycosis A481 Legionnaires' disease
More informationStreptococci facultative anaerobe
THE GENUS STREPTOCOCCUS The genus Streptococcus obtains Gram-positive cocci, nonmotile, nonsporeforming, arranged mostly in chains or in pairs. Most species are facultative anaerobes. Some of streptococci
More informationPATHOGEN DETECTION WITH THE FILMARRAY
PATHOGEN DETECTION WITH THE FILMARRAY The System Sample-to-Answer in an Hour Single sample Multiple samples The FilmArray integrates sample preparation, amplification, detection, and analysis all into
More informationDISEASE OUTBREAKS SUMMARY
DISEASE OUTBREAKS SUMMARY Outbreaks may be defined as (a) clusters of cases related in time and place or (b) occurrence of disease above a baseline or threshold level in a defined location. In Los Angeles
More informationValidation FTD Respiratory pathogens 33
Validation FTD Respiratory pathogens 33 32 reactions (catalog no. FTD-2P.3-32) 64 reactions (catalog no. FTD-2P.3-64) Qualitative assay for in vitro diagnostics Validated with: Applied Biosystems 7500
More informationBACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year )
BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year 2012-2013) 19. 10. 2012. Introduction in microbiology, bacterial taxonomy, general bacterial prop Bacterial structures, biosynthesis
More informationBabak Valizadeh, DCLS
Laboratory Diagnosis of Bacterial Infections of the Respiratory Tract Babak Valizadeh, DCLS 1391. 02. 05 2012. 04. 25 Babak_Valizadeh@hotmail.com Biological Safety Cabinet Process specimens in biological
More informationEvaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella
JCM Accepts, published online ahead of print on 6 May 2009 J. Clin. Microbiol. doi:10.1128/jcm.00397-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationRespiratory tract infections. Krzysztof Buczkowski
Respiratory tract infections Krzysztof Buczkowski Etiology Viruses Rhinoviruses Adenoviruses Coronaviruses Influenza and Parainfluenza Viruses Respiratory Syncitial Viruses Enteroviruses Etiology Bacteria
More informationClient Services Manual
Diagnostic Innovation Improving Health Client Services Manual [ Revised 12.21.18 ] Table of Contents About / Instructions Directory... 2 About Diatherix... 3 Specimen Preparation Instructions... 4 Packaging
More informationCLIENT SERVICE MANUAL
CLIENT SERVICE MANUAL [ V1.2 08.14.13] Linking Diagnostics to Therapeutics 2016 Diatherix Laboratories, LLC. All rights reserved. CSM -10.13.16 Linking Diagnostics to Therapeutics [ Revised 10.13.16 ]
More informationInfluenza Weekly Surveillance Bulletin
Influenza ly Surveillance Bulletin Northern Ireland, ( 1 January ) Summary GP consultation rates for combined flu/ FLI decreased from 1./, population (updated) in week to./, in week (4% decrease). o flu/fli
More informationSniffs and Sneezes can Spread Diseases: Year- Round Protection. Jim Gauthier, MLT, CIC Senior Clinical Advisor, Infection Prevention
Sniffs and Sneezes can Spread Diseases: Year- Round Protection Jim Gauthier, MLT, CIC Senior Clinical Advisor, Infection Prevention Objectives Look at various viral respiratory illnesses Discuss year-round
More informationChain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host
Goals Microbiology of Healthcare-associated Infections William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Research Professor of Medicine, University
More informationCell counting (EtBr) Before cell-lysis. Cell-lysis by 3% SDS beads beating. After cell-lysis
Key words Sample Cell counting (EtBr) DNA extraction Cell-lysis by 3% SDS beads beating Before cell-lysis After cell-lysis Cell-lysis efficiency (Maintained70%) PCR PCR amplification of partial fragments
More informationTABLE OF CONTENTS. About / Instructions. Test Catalog. Collection Procedures. Supplies / References. Directory...2 About Diatherix...
TABLE OF CONTENTS About / Instructions Directory...2 About Diatherix...3 Specimen Preparation Instructions...4 Packaging and Shipping Instructions...5 Test Catalog Diatherix Panel List...6 Diatherix Panel
More informationCLIENT SERVICE MANUAL
CLIENT SERVICE MANUAL [ V1.2 08.14.13] Linking Diagnostics to Therapeutics [ Revised 05.25.16 ] TABLE OF CONTENTS About / Instructions Directory...2 About Diatherix...3 Specimen Preparation Instructions...4
More informationAcute lower respiratory infections
18 Acute lower respiratory infections Introduction i Key points Community-acquired pneumonia is the most frequent cause of death from infection in Europe. The majority of patients with pneumonia are treated
More informationZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg
ZINEX Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg Tablets Action Cefuroxime axetil owes its bactericidal activity to the parent compound cefuroxime. Cefuroxime is a well-characterized
More informationCHMP List of questions
28 June 2018 EMA/CHMP/346196/2018 To be addressed by the marketing authorisation holders for bacterial lysatescontaining medicinal products for respiratory conditions Referral under Article 31 of Directive
More informationOntario Respiratory Pathogen Bulletin I
Ontario Respiratory Pathogen Bulletin I 2017-2018 SURVEILLANCE WEEK 3 (January 14, 2018 January 20, 2018) This issue of the Ontario Respiratory Pathogen Bulletin provides information on the surveillance
More informationThe cost-saving, effective diagnoses of melioidosis in Cambodia. Vanaporn Wuthiekanun Faculty of Tropical Medicine Mahidol University
Angkor hospital for Children at Siem Reap The cost-saving, effective diagnoses of melioidosis in Cambodia Vanaporn Wuthiekanun Faculty of Tropical Medicine Mahidol University Angkor Wat Ta Prohm Bayon
More informationInfection Data: Form Updates
Infection Data: Form Updates Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC Overview Why is infection data important?
More informationSkin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease
Skin reactivity to autologous bacteria 149 Original Article Skin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease J. Halasa 1, M. Halasa
More informationReport on. Thailand Gender-Disaggregated Statistics 2008
Report on Thailand Gender-Disaggregated Statistics 2008 Office of WomenÊs Affairs and Family Development Ministry of Social Development and Human Security in collaboration with United Nations Development
More informationInfluenza Weekly Surveillance Bulletin
Influenza ly Surveillance Bulletin Northern Ireland, (11-17 December ) Summary All indicators of influenza virus activity have increased. GP consultation rates for combined flu/ FLI increased from 28.1/,
More informationINVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND
INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE IN COLLABORATION WITH THE IRISH MENINGITIS
More informationPotential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.
In the name of God Principles of post Tx infections 1: Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections. Infection processes can progress
More informationInfluenza Weekly Surveillance Bulletin
Influenza ly Surveillance Bulletin Northern Ireland, 7- (19 November December 1) Summary Influenza activity in Northern Ireland remains at low levels. The GP combined flu/fli consultation rate increased
More informationVolume 2 February 2011 LABORATORY UPDATE
Volume 2 February 2011 LABORATORY UPDATE www.dlolab.com Routine Testing New Tests Bacterial Pneumonia Panel... 3 Gastrointestinal Panel... 4 Infectious Disease Panel... 5 Respiratory Infections Panel...
More informationClient Services M anual
Diagnostic Innovation Improving Health Client Services M anual [ Revised 09.27.18 ] Table of Contents About / Instructions Directory...2 About Diatherix...3 Specimen Preparation Instructions...4 Packaging
More informationUpper...and Lower Respiratory Tract Infections
Upper...and Lower Respiratory Tract Infections Robin Jump, MD, PhD Cleveland Geriatric Research Education and Clinical Center (GRECC) Louis Stokes Cleveland VA Medical Center Case Western Reserve University
More informationFor the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS. Cefuroxime Axetil Tablets IP 125/250/500mg
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS Cefuroxime Axetil Tablets IP 125/250/500mg QUALITATIVE AND QUANTITATIVE COMPOSITION CEFTUM TABLETS 125
More informationINVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND
INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE IN COLLABORATION WITH THE IRISH MENINGITIS
More informationDownloaded from:
Muller-Pebody, B; Crowcroft, NS; Zambon, MC; Edmunds, WJ (2006) Modelling hospital admissions for lower respiratory tract infections in the elderly in England. Epidemiology and infection, 134 (6). pp.
More informationBrief Communication Clinical Microbiology
Brief Communication Clinical Microbiology Ann Lab Med 2017;37:531-535 https://doi.org/10.3343/alm.2017.37.6.531 ISSN 2234-3806 eissn 2234-3814 Comparison of a New Matrix-Assisted Laser Desorption/Ionization
More informationHYPOCHLOROUS ACID (HOCl) Our Body's immune system protector in a BOTTLE
AQUAOX IS A REVOLUTIONARY DISINFECTION SOLUTION WHICH ACTIVE INGREDIENT HOCL IS NON HAZARDOUS, HAS NO FRAGRANCE, AND IS SAFE ON ALL SURFACES (AND ON SKIN.) HYPOCHLOROUS ACID (HOCl) Our Body's immune system
More information1/9/ :00:00AM 1/9/ :40:15AM 6/9/2017 9:19:16AM A/c Status. Test Name Results Units Bio. Ref. Interval. Nasal Swab
LL - LL-ROHINI (NATIONAL REFERENCE 135091523 Age 36 Years Gender Female 1/9/2017 120000AM 1/9/2017 114015AM 6/9/2017 91916AM Ref By Final RESIRATORY COMREHENSIVE ANEL (33 ATHOGENS) RESIRATORY ANEL 1 #
More informationEmerging Respiratory Infections NZ Amanda McNaughton Respiratory Physician CCDHB Wellington
Emerging Respiratory Infections NZ 2015 Amanda McNaughton Respiratory Physician CCDHB Wellington Respiratory Infection: overview Influenza virus Clinical picture Emerging infection New Zealand Influenza
More informationURIs and Pneumonia. Elena Bissell, MD 10/16/2013
URIs and Pneumonia Elena Bissell, MD 10/16/2013 Objectives Recognize and treat community acquired PNA in children/adults Discern between inpatient and outpatient treatment of PNA Recognize special populations/cases
More informationEnvironmental Monitoring, risk assessment and responsibilities
Environmental Monitoring, risk assessment and responsibilities Medical Devices Directive -93/42/EEC ANNEX I ESSENTIAL REQUIREMENTS 8. Infection and microbial contamination 8.1. The devices and manufacturing
More informationUniversity of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology
University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology This material is supported in part by unrestricted educational
More information27/11/2012. Parainfuenza 1, 2 3 Rhinovirus Coronavirus Adenovirus Respiratory syncytial virus (RSV) Chlamydophila pneumoniae Mycoplasma pneumonite
8 «Evidence-based Medicine-» 27/11/2012,,,, : :,,,,,,,, (30%-50%) () (5%-10%) (40%-50%) 20% Infuenza A B Parainfuenza 1, 2 3 Rhinovirus Coronavirus Adenovirus Respiratory syncytial virus (RSV) Chlamydophila
More informationANWICU knowledge
ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted
More informationINVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND
INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE IN COLLABORATION WITH THE IRISH MENINGITIS
More informationEpidemiology of Infectious Complications of H1N1 Influenza Virus Infection
Epidemiology of Infectious Complications of H1N1 Influenza Virus Infection Lyn Finelli, DrPH, MS Lead, Influenza Surveillance and Outbreak Response Epidemiology and Prevention Branch Influenza Division
More informationPediatric influenza-associated deaths in Arizona,
Pediatric influenza-associated deaths in Arizona, 2004-2012 (Poster is shared here as an 8.5 x11 document for easier viewing. All content is identical, though graphs and tables are formatted differently.)
More informationSITUATION ANALYSIS OF CHILD DROWNING SURVEILLANCE IN THAILAND
SITUATION ANALYSIS OF CHILD DROWNING SURVEILLANCE IN THAILAND Research Team Members: Mrs. Suchada Gerdmongkolgan Ms. Som Ekchaloemkiet Mrs. Auraphin Sublon Mrs. Roongjit Termtor Mrs. Kanjanee Dumnakkaew
More informationNosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria
Nosocomial Pneumonia Meredith Deutscher, MD Troy Schaffernocker, MD Ohio State University Burden of Hospital-Acquired Pneumonia Second most common nosocomial infection in the U.S. 5-10 episodes per 1000
More informationSurveillance of Influenza in Northern Ireland
Surveillance of Influenza in Northern Ireland 2016 2017 Contents Summary... 1 Introduction... 3 Enhanced influenza surveillance systems... 3 In-hours Sentinel GP Practice surveillance... 3 GP Out-of-Hours
More informationChallenges and best practices in real-time prediction of infectious disease: a case study of dengue in Thailand
University of Massachusetts Amherst From the SelectedWorks of Nicholas G Reich 215 Challenges and best practices in real-time prediction of infectious disease: a case study of dengue in Thailand Nicholas
More informationan inflammation of the bronchial tubes
BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious
More informationPneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2016
Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention Basics of Infection Prevention 2-Day Mini-Course 2016 Objectives Differentiate long term care categories of respiratory infections
More informationVOLOXAL. Composition each tablet contains levofloxacin 500 & 750 mg
VOLOXAL Composition each tablet contains levofloxacin 500 & 750 mg Tablets Action Bactericidal; as a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA-gyrase complex and topoisomerase IV
More informationLABORATORY TRENDS. Laboratory News PUBLIC HEALTH MICROBIOLOGY & REFERENCE LABORATORY. Vancouver, BC. December 21, 2011.
& REFERENCE Laboratory News Genome BC Water Grant Earlier in 11, PHMRL leaders Drs. Patrick Tang and Judy Isaac-Renton, along with Drs. Natalie Prystajecky and Jennifer Gardy and supported by many colleagues
More informationBACTERIAL INTERVENTIONS TO INCREASE BLOOD SAFETY
BACTERIAL INTERVENTIONS TO INCREASE BLOOD SAFETY Jennifer Allen National Bacteriology Laboratory on behalf of Dr. C P McDonald Head of Bacteriology National Bacteriology Laboratory NHSBT Klebsiella oxytoca
More informationPNEUMONIA IN CHILDREN. IAP UG Teaching slides
PNEUMONIA IN CHILDREN 1 INTRODUCTION 156 million new episodes / yr. worldwide 151 million episodes developing world 95% in developing countries 19% of all deaths in children
More informationSurveillance of Healthcare Associated Infections in Scottish Intensive Care Units
Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units Annual report of data from January 2010 to December 2010 Scottish Intensive Care Society Audit Group 1 Health Protection
More informationTorres, Brian Carlmichael L., Ma. Luisa G. Daroy, Juan s. Lopez, Vanessa Oh, Marie Joan Loy, Prospero ma. Tuaño, and Ronald R. Matias Research and
Torres, Brian Carlmichael L., Ma. Luisa G. Daroy, Juan s. Lopez, Vanessa Oh, Marie Joan Loy, Prospero ma. Tuaño, and Ronald R. Matias Research and Biotechnology Division and International Eye Institute
More informationHealthcare-associated infections acquired in intensive care units
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit
More informationUVGI APPLIED DURING ORTHOPEDIC SURGERY AND THE RATE OF INFECTION
UVGI APPLIED DURING ORTHOPEDIC SURGERY AND THE RATE OF INFECTION UVGI BASICSB Mercury Vapor lamps produce 253.7 nm radiation which breaks down the DNA and RNA of microorganisms, scrambling their genetic
More informationCoordinate shipping to the Oregon State Public Health Lab through your local health department
Interim Guidance for Clinicians on Testing, Evaluation, and Infection Prevention in the Management of Patients with Suspected Novel Respiratory Infections: Influenza A H7N9 and Middle East Respiratory
More informationHIV AND LUNG HEALTH. Stephen Aston Infectious Diseases SpR Royal Liverpool University Hospital
HIV AND LUNG HEALTH Stephen Aston Infectious Diseases SpR Royal Liverpool University Hospital Introduction HIV infection exerts multiple effects on pulmonary immune responses: Generalised state of immune
More informationSurveillance of influenza in Northern Ireland: season
Surveillance of influenza in Northern Ireland: 2017 2018 season Contents Introduction... 3 Enhanced influenza surveillance systems... 3 In-hours GP Practice surveillance... 3 GP Out-of-Hours surveillance...
More informationTable 1: Summary of Texas Influenza (Flu) and Influenza-like Illness (ILI) Activity for the Current Week Texas Surveillance Component
Texas Surveillance Report 2017 2018 Season/2018 MMWR Week 03 (Jan. 14, 2018 Jan. 20, 2018) Report produced on 1/27/2018 Summary activity remains high across the state of Texas. Compared to the previous
More informationManagement of URTI s in Children
Management of URTI s in Children Robin J Green PhD Antibiotics - Dilemmas for General Practitioners Antibiotic overuse = Resistance Delay in antibiotic use = Mortality Patient expectation Employer expectation
More informationLower respiratory tract infections
12 Community-Acquired : Bacteriological Profile and Microbiological Investigations Ravi Kumar 1, Canna Ghia 2, Shaumil Waghela 3, Harish Thanusubramanian 4, Gautam Rambhad 5 Introduction Lower respiratory
More informationTarrant County Influenza Surveillance Weekly Report CDC Week 02: January 08 14, 2012
Tarrant County Public Health Division of Epidemiology and Health Information Tarrant County Influenza Surveillance Weekly Report CDC Week 02: January 08 14, 2012 Influenza Activity Code, County and State
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal catastrophes in ICU, 1017 1044. See also specific types, e.g., Abdominal compartment syndrome treatment of, 1032 1037 antimicrobial,
More informationInfrastructure and methods for real-time predictions of the 2014 dengue fever season in Thailand
Infrastructure and methods for real-time predictions of the 214 dengue fever season in Thailand Nicholas G. Reich, Stephen A. Lauer, Krzysztof Sakrejda, Sopon Iamsirithaworn, Soawapak Hinjoy, Paphanij
More informationTarrant County Influenza Surveillance Weekly Report CDC Week 17: April 22-28, 2012
Tarrant County Public Health Division of Epidemiology and Health Information Tarrant County Influenza Surveillance Weekly Report CDC Week 17: April 22-28, 2012 Influenza Activity Code, County and State
More informationKENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #
Inc. Efficacy: Hospital Disinfection (at ½ ounce per gallon) Kennel Kare SC is bactericidal according to the AOAC Use Dilution Test method on hard inanimate surfaces modified in the presence of 5% organic
More informationINVASIVE MENINGOCOCCAL DISEASE (IMD), OTHER BACTERIAL MENINGITIS, HAEMOPHILUS INFLUENZAE & VIRAL MENINGITIS INFECTIONS IN IRELAND
INVASIVE MENINGOCOCCAL DISEASE (IMD), OTHER BACTERIAL MENINGITIS, HAEMOPHILUS INFLUENZAE & VIRAL MENINGITIS INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE (HPSC) IN COLLABORATION
More informationTarrant County Influenza Surveillance Weekly Report CDC Week 06: February 05 11, 2012
Tarrant County Public Health Division of Epidemiology and Health Information Tarrant County Influenza Surveillance Weekly Report CDC Week 06: February 05 11, 2012 Influenza Activity Code, County and State
More informationTreatment of febrile neutropenia in patients with neoplasia
Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece
More informationINVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND
INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE IN COLLABORATION WITH THE IRISH MENINGITIS
More informationClinical Practice Guidelines for Nursing- and Healthcareassociated Pneumonia (NHCAP) [Complete translation] $
respiratory investigation 51 (2013) 103 126 Contents lists available at SciVerse ScienceDirect Respiratory Investigation journal homepage: www.elsevier.com/locate/resinv Guideline Clinical Practice Guidelines
More information